5 Mar 2015

Vol.17.Special Issue: HEALTHCARE QUARTERLY (Longwoods) Cancer Care Ontario:Quality,Performance and Partnership

Includes article by Rhodes Scholar U.Tor Dalla Lana School of Public Health (Health Policy ) Prof.Adalsteinn D. BROWN MA MPH(Harvard) DPhil (Oxon.) pp 47-50 "The Challenge of Quantity Improvement at the System Level. Whither CCO? (Cancer Care Ontario)

Prof.Brown discusses the Cancer System Quality Index (CSQI) and the use of "SYNOPTIC PATHOLOGY". (Etymology:: taking a General or Comprehensive view)

Definition of Synoptic Reporting (COLLEGE of AMERICAN PATHOLOGISTS)
The CAP has developed this list of specific features that define synoptic reporting formatting:
1. All required cancer data from an applicable cancer protocol must be included in the report and must be displayed using a format consisting of the required checklist item (required data element), followed by its answer (response), e. g. “Tumor size: 5.5 cm”. Outline format without the paired required data element (RDE): response format is not considered synoptic.
2. Each diagnostic parameter pair (checklist RDE: response) is listed on a separate line or in a tabular format, to achieve visual separation.
Note: the following are allowed to be combined on the same line:
a. Anatomic site or specimen, laterality and procedure
b. Pathologic Staging Tumor Node Metastasis (pTNM) staging elements
c. Negative margins, as long as all negative margins are specifically enumerated
For example:
o Headers may be used to separate or group data elements
o Any line may be indented to visually group related data elements or indicate a subordinate relationship
o Text attributes (e.g., color, bold, font, size, capitalization/case, or animations) are optional
o Blank lines may be used to separate data elements and group related elements
3. If multiple responses are permitted for the same data element, the responses may be listed on a single line.
4. The synopsis can appear in the diagnosis section of the pathology report, at the end of the report or in a separate section, but all RDE and responses must be listed together in one location.
5. Additional items (not required for the CAP checklist) may be included in the synopsis but all required RDE must be present.
6. Narrative style comments are permitted in addition to, but are not as a substitute for the synoptic reporting. It is not uncommon for narrative style comments to be used for clinical history, gross descriptions and microscopic descriptions.
Additional Specifications and Options
• Data elements may be presented in any order in the report.
• Two data element names may not be listed on the same line, with the following exceptions:
o Anatomic site or specimen, laterality, and procedure
o Negative margins. Example: for colorectal carcinoma resection specimens, negative proximal, distal, and radial margins may be listed on one line
o Pathologic staging: pT, pN, and pM categories may be listed on one line. It is not necessary to include definitions of the pT, pN, and pM categories in the report.
Otherwise, only multiple values pertaining to the same data element may be listed on the same line.
• Diagnostic headlines may be included that contain some data elements in non-standard format (e.g., "INVASIVE CARCINOMA OF THE RIGHT BREAST.") However, if information in the headline includes a required element and the headline does not use the single line or multi-line format, the required information in the headline must also appear in the single line or multi-line format in the same report. December 13, 2011 - v2.0

 • Narrative comments may reference required or optional data elements. However, data
elements and values that appear in narrative comment may not be properly abstracted
and auditors are not to consider the data element and its value as having been included in a report, unless the information also appears in a properly formatted single line or multi-line statement.
• Data that are not listed as required or optional in an applicable cancer protocol may be included in any format. Examples include patient identification data (name, date of birth) or administrative data (report date, accession number)
• Required and optional data elements listed in the applicable cancer protocol may be combined into one report or broken up into separate reports. For example, separate paper reports or computer screens might be used to report histological and molecular findings, or to report gross and microscopic findings, or to report examinations of different specimens.
The CAP has developed a few examples of synoptic reporting (attached) for the use of the COC as training tools for COC inspectors. Sample reports 1-6 are examples of acceptable synoptic reporting; Sample reports 7 and 8 do not show acceptable synoptic style reporting. CAP recommends that CoC surveyors focus their evaluation of synoptic reporting only on definitive resection specimens and not biopsies at this time.


Return to CAP Home

Printable Version
  Feature Story
title
  cap today
With synoptic reports, big picture in a small package
July 2003
Eric Skjei

Labs nationwide are working to ensure that their pathology reporting systems conform to the CAP cancer protocols, which accredited hospital cancer programs must begin using by Jan. 1, 2004.
Fearful that traditional free-text reports might not do the trick, many labs have implemented backup systems ranging from templates in Word or Word Perfect to simple paper checklists and notebook-based reference systems to try to ensure that the reports meet the new requirements of the American College of Surgeons Commission on Cancer.
A hospital-based laboratory system in Sioux Falls, SD, is pioneering the use of a digital synoptic reporting system for CoPathPlus, from Cerner Corp. The system functions as a database devoted to pathology reporting functions—in this case, cancer protocols. Cerner also provides a synoptic reporting solution for its Millennium PathNet platform.
The synoptic reporting that Keith Anderson, MD, is doing in Sioux Falls is a “concise standardized reporting that includes all data needed for accurate staging, treatment, and prognosis,” he says.
“‘Synoptic’ implies that you’re condensing things, making it more tight, if you will,” says Dr. Anderson, chief of pathology, Sioux Valley Hospital, University of South Dakota Medical Center. “My bias is that we’re not making it less, but we’re standardizing it and making sure we get everything in there that we want to get in there.”
In pathology reporting, “synoptic” traditionally has referred to checklists of various types intended to ensure that essential elements are not omitted from reports. In Cerner’s synoptic reporting product, as implemented by LCM Pathologists, P.C., at Sioux Valley Hospital, synoptic translates into preformatted templates or worksheets, developed by Dr. Anderson and
his colleagues, in which specific fields are assigned to given elements in the protocol.
The key to using worksheets is to be able to retrieve answers to questions quickly and accurately. Having to read free-text reports to do so is time consuming and error prone. Sioux Valley has found that using the synoptic reporting coding product allows it to reduce as many as 45 pages of cancer protocol to two to three pages of worksheet on the computer screen.
The Sioux Valley worksheets are not only comprehensive and efficient, they are standardized, which may make it easier to share data across reports
in the future. “Our bias is that we want to try to capture that data for future clinical research as well,” says Dr. Anderson. “That would be an ultimate goal.”
Better than free text
A product with database-like capabilities offers distinct advantages over traditional free-text reporting systems. Consider the simple task of searching for tumors of a specific size. “If you wanted to look for all the cases that had a particular tumor size, for example, you could select the appropriate tumor type, search for all those of a certain size, or even sort by size in ascending or descending rank order,” says Tom Schnabel, LCM Pathologists’ business manager.
To do something even remotely comparable in a free-text report would require manually inspecting each report and would be prohibitively time consuming. “The problems with free-text searching are many and varied,” Schnabel says. If you specify “tumor size” as your search term, for example, you might, depending on your search function, get every report that contains the word “tumor” and every report that contains the word “size”—in other words, a lot of material you don’t want. Or if you search for a specific numerical value, Schnabel says, you might, depending on your search capabilities, receive everything that has that number associated with it, whether it’s related to tumor size or not. Or your search might find the word or phrase in the text accurately and repeatedly but fail to keep track of the number of instances found.
“But in the CoPath product,” he says, “‘tumor size’ is in the synoptic value dictionary under the value of ‘tumor size,’ and it will search for just those cases that have that value point populated and for just the value or range of values you specify.”
LCM went live with the new synoptic coding product in January, and Dr. Anderson estimates that the group has been adding about two worksheets per month ever since. “I think it’s working pretty well,” he says. “There are plenty of bumps in the road because biologic systems are highly variable, and we keep coming across oddball cases that don’t fit quite the way we had envisioned them fitting in this digitized report format.”
Dr. Anderson says the reports themselves do not have a digitized or preformatted appearance; they look very much like their free-text brethren. “We’ve tried to make it look like close to what we were dictating as reports before, but we’re able to standardize more from my report to my partner’s report,” he says. Every worksheet also supports a fair amount of additional free-texting capability to capture information that doesn’t lend itself to preformatted coding solutions.
Top five cancer types
Only a small percentage of the reports Dr. Anderson’s group issues are produced using the synoptic reporting system since it is targeted only at cancer reporting. But within the cancer report function, a high percentage of the most common cancers seen by the group are being reported using the product. “If you were to say, look at all the breast cancers, for example, the product is basically handling all of them,” Dr. Anderson says.
“We’re proceeding by tumor type,” Schnabel adds. “We did breast tumors first; then we did colon resections, lymph nodes, and then endometrium, uterine tumors.” The group’s understanding is that the Commission on Cancer inspection focuses on the top five most common cancers seen in a hospital program. “So we’re trying to get our worksheets out for our most common tumors and not worry too much about the 40th most common type,” Dr. Anderson says.
The product can be designed to prompt the user if a required field is
not completed. It can even predesignate a set of specific choices, allow the user to select from that list, and require the user to make only one selection.
It also supports additional explanatory material. “We can build in educational notes,” says Dr. Anderson. “If somebody is not sure what a term means and it’s something we don’t address very often, we might note, for example, that this diagnosis requires X percent of something, specifying what that percentage is so the user is reminded as they move through
the worksheet.”
Support from Cerner has been excellent, according to Dr. Anderson and Schnabel. “Part of that is because we were the first site to start using this on a live basis, and they really dedicated resources to us to get it developed and up and running,” says Dr. Anderson.
The synoptic product is available on the Millennium PathNet version 2003.02 or the CoPathPlus version 2.3 or higher. “We were the fourth site in the country to go live on version 2.3,” Schnabel notes. “But as they roll out 2.3, there will be more people that have this available to them.”
Consistency and productivity
Clinicians, of course, benefit from consistency across pathology reports. “Even if we’re not worried about having all the appropriate staging information and treatment information in the report, it can be very confusing for clinicians to read my report and then see that of a partner who has a totally different approach to the way they put their report together,” Dr. Anderson says. “Clinicians can find it difficult to pull out the correct information.” That any pathology report produced by the system can offer the same information in the same order is an important, if intangible, benefit.
Clinicians offer positive feedback about the reports when asked, but perhaps more important is that the implementation has been relatively seamless and has not provoked a lot of negative comments or queries. “As the business manager,” Schnabel says, “I think that not getting any negative comments is in itself proof that we’re meeting their needs—or we would certainly be hearing about it.”
Although productivity has not been targeted as a primary benefit, there is little doubt that the CoPath product is making it easier to comply with the protocols than would paper-based methods.
“In terms of how fast we can do this versus how fast we can dictate it, I don’t think we’re going to see a whole lot of difference,” Dr. Anderson says. “But I do strongly believe what we’re doing is faster than what we could do if I were pulling out the workbook, finding page 15 that has colon cancer on
it, and stepping through that page to make sure I had done all of those things right.”
While dictating from memory is faster than working through the worksheet on the computer, knowing that it’s critical to get in all those staging points and not miss any is the higher priority, analogous to the checklist an airline pilot uses, says Dr. Anderson. A pilot might be able to get in the air quicker if he or she doesn’t have to step through the checklist, but neither the pilot nor anyone flying with the pilot is going to feel as comfortable.
Dr. Anderson’s group of 16 pathologists runs the gamut with regard to comfort in using computer tools. “If you have someone who is very computer savvy, they can be up and running in a matter of minutes,” he says. “If you have somebody who is totally computer phobic, they’re going to be dictating it off a piece of paper and the secretarial staff is going to be putting it in. We’ve got all ends of the spectrum here.”

1 Mar 2015

DAILY MAIL & GUARDIAN: NHS GP SHORTAGE due to feminisation of medicine.

NHS plea to expat GPs in Australia: come home

Call for those on career breaks to plug the gap as shortfall of 1,000 family doctors in England is revealed

doctors
The accident and emergency department at Bradford Royal Infirmary, West Yorkshire. Photograph: Christopher Thomond

A shortfall of 1,000 GPs in England is revealed in figures published on Sunday, with the NHS being forced to advertise in Australia for British doctors on career breaks to come home and plug the gaps.
Staffing levels have failed to keep pace with the increase in population, according to an analysis commissioned by the Labour party. If the number of people per GP had remained at the 2009 level, there would be an extra 1,063 GPs, which Ed Miliband’s party claims would bring huge relief to the system.
British GPs working in Australia have been targeted through an advertisement in two medical magazines urging them to return home and practise in the UK. The advert promises a “fully funded induction and returner scheme” if they return, and emphasises that practices taking part in the scheme are “looking to recruit permanent GPs”.
The advert, placed by NHS England’s Shropshire and Staffordshire area team and Health Education Midlands, ran in November and December.
The shadow health secretary, Andy Burnham, claims that the new figures, provided by the House of Commons library, prove that the NHS has a GP recruitment crisis.
Difficulties faced by patients trying to get GP appointments have been cited as one of the reasons for a huge surge in the number of people arriving at hospital A&E departments.
Burnham said: “GP services have gone into freefall under this government. David Cameron promised to put GPs at the heart of the NHS, but instead caused a new GP recruitment crisis. Under his government, it is getting harder and harder to get a GP appointment as a result.”
NHS England recently announced a £10m strategy to tempt medical graduates to become GPs, and experienced GPs to delay retirement. The ideas included a new national scheme for returners and cash inducements if they agree to work in an area with a shortage of doctors.
Advertisement
The Department of Health is understood to be concerned by the current ratio of GPs per person. National figures from Health Education revealed that just 23% of trainees in 2014 planned to go into GP training. The figures showed a fall of 6.2% on last year, with just over 5,000 applicants in total.
Sir David Metcalf, chairman of the migration advisory committee, criticised the coalition’s record on GP recruitment last month, when explaining why he had not put GPs on the shortage list of occupations that allows more non-EU recruitment.
“There is no shortage of medical students. The issue is that they have got the incentives wrong and they are not encouraging enough people to go into GP training,” said Metcalf.
The soaring number of female doctors working part-time in surgeries was cited last week as a contributory factor in the GP recruitment crisis.
The migration advisory committee said that the “feminisation of the GP workforce” meant more trainees were needed to maintain the same service for patients because women were more likely to work shorter hours than men after they have children. This has contributed to an annual shortage of 450 to 550 GPs, the committee warned.

25 Feb 2015

Ont.Min.Health:NEW REGISTRY OF (4,700) AVAILABLE INPATIENT PSYCHIATRIC BEDS for 13-million Ontarians.

Today Ont. Min.Health Rhodes Scholar Dr.Eric HOSKINS MD(McMaster) MSc(Lond.Trop.Med.) PhD(Oxon.) Dip.Health.Econ(Aberdeen) made the announcement at the luxurious Dr.Riva (Appleby) GERSTEIN CC O.Ont PhD.(Tor-Psych..) Crisis Centre (10 beds).at 100 Charles St.East.. There is a second GERSTEIN Centre at 1045 Bloor St.West.(14 beds) Both funded by the Central Toronto LHIN (Local Health Initiative Network (Chmn. Mrs Angela FERRANTE) C.-T. LHIN budget $4.2-billion.

This is similar to the plan started in the late 1940s by the London King Edward's Hosp Fund which allowed GPs to phone and find the nearest Hosp bed available. The Fund was first financed in the early 1900s by the then "Richest Canadian" George Stephen 1rst Baron of Mount Stephen GCVO..

23 Feb 2015

American Sexually Transmitted Diseases Assn

Sexually Transmitted Diseases - Current Issue
Chlamydia Test Results Were Associated With Sexual Risk Behavior Change Among Participants of the Chlamydia Screening Implementation in the Netherlands
Sunday, March 01, 2015 1:00 AM
imageObjective: To examine the effect of a laboratory-confirmed Chlamydia trachomatis (Ct) test result on subsequent sexual risk behavior in a large population-based screening program. Methods: The study population consisted of 16- to 29-year-old participants of the Chlamydia Screening Implementation who completed Ct testing and questionnaires in 2 or more rounds. The influence of a Ct test result on sexual behavior was analyzed by generalized estimating equation models, in which the Ct test result of the previous round was the independent variable and 1 of the 8 sexual risk behavior indicators was the dependent variable, adjusted for covariates. Results: Of 48,910 Chlamydia Screening Implementation participants with completed questionnaires and test results, 14.1% (n = 6802) and 2.6% (n = 1272) completed 2 and 3 rounds, respectively, and were included in this study. Analysis showed that Ct positives less often reported to “never” use condoms with a casual partner (%change pretest/posttest = −5.7% [−10.3 to −0.9]), whereas Ct negatives less often reported to “always” use condoms with a casual partner (−4.6% [−6.4 to −2.8]; odds ratio [95% confidence interval], 1.75 [1.09 to 2.80]). Ct positives also had more sexual partners in the subsequent round than did participants with a Ct-negative test result (relative risk [95% confidence interval], 1.14 [1.01 to 1.29]). Conclusions: Ct test results were associated with subsequent sexual risk behavior. In general, Ct positives were more likely to change their behavior after a Ct test result in a more positive and protective direction than Ct negatives, who were more likely to change their behavior toward more risky behavior. Effects over time after a Ct test should be investigated further, especially in the Ct negatives.


Association of the In Vitro Susceptibility of Clinical Isolates of Chlamydia trachomatis With Serovar and Duration of Antibiotic Exposure
Sunday, March 01, 2015 1:00 AM
imageBackground: The presence of persistent Chlamydia trachomatis infection after treatment does not always correlate with in vitro susceptibility testing. Methods: The in vitro minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of azithromycin, clarithromycin, roxithromycin, doxycycline, tetracycline, ofloxacin, and penicillin were tested against 61 clinical isolates of C. trachomatis on 6 serovars, and the MIC/MBC of azithromycin and ofloxacin at different points in time after antibiotic administration to infected cultures. Results: Of the 7 antibiotics tested, clarithromycin showed the greatest activity against C. trachomatis isolates with MIC90 of 0.032 μg/mL and MBC90 of 0.064 μg/mL, followed by doxycycline with MIC90 0.064 μg/mL and MBC90 0.064 μg/mL, and azithromycin with MIC90 0.160 μg/mL and MBC90 0.320 μg/mL. Azithromycin had roughly the same MIC50 values (0.08 μg/mL) as the other serovars isolates tested, and other antibiotics showed a 2- to 4-fold difference in MICs50 between serovars. In addition, an increase in the azithromyin MIC was observed by 8 hours and the ofloxacin MIC by 16 hours. At 24 hours, the azithromycin MICs were greater than 40 μg/mL and ofloxacin MICs were greater than 64 μg/mL. Conclusions: The current data demonstrated that the antimicrobial susceptibility of C. trachomatis was influenced by both the serovar type and the duration of exposure to antibiotics in infected cultures.


Confirmation of High Specificity of an Automated Enzyme Immunoassay Test for Serological Diagnosis of Syphilis: Retrospective Evaluation Versus Results After Implementation
Sunday, March 01, 2015 1:00 AM
imageBackground: The optimal algorithm for serological syphilis screening is still a matter of debate. We have previously evaluated the performance of the Bioelisa Syphilis 3.0, using a selection of archived sera, and in this study compare these results with the Bioelisa results after clinical implementation. Methods: All Bioelisa Syphilis 3.0 results obtained since clinical implementation were analyzed. Bioelisa-positive or borderline samples were retested using Treponema pallidum particle agglutination, rapid plasma reagin test, fluorescent treponemal antibody-absorption test, and/or immunoblot. On sera sent in together with cerebrospinal fluid, occasionally both the T. pallidum particle agglutination and Bioelisa were performed. Results: The Bioelisa was performed on 14,622 sera. Bioelisa-positive samples, which were not retested by the previously described assays, were withdrawn from the database (n = 36). In 1.3% of the samples (187/14,586), the Bioelisa was positive or borderline and, ultimately, 115 sera were considered true positive (prevalence 0.8%). The specificity of the Bioelisa was 99.5%. Conclusions: Based on the results of all performed diagnostic assays, the specificity of the Bioelisa of 99.5% is very consistent with that found in the initial study (100%; 95% confidence interval was 98.0%–100%). Interpreting (positive) test results is difficult in the absence of a gold standard, especially when the disease prevalence is low. Results should be viewed in the light of the patients’ characteristics.

19 Feb 2015

UK DAILY MAIL Where are the Wealthy in the USA?


The map was made based on income estimates from the 2008-2012 American Community Survey, which were used to determine the median household income by town. The richest town in each state were usually small towns with populations between 1,000 and 8,000 and usually not far from major cities. Hidden Hills, California and Chevy Chase, Maryland come in at the top of the list, while Jericho Vermont and Gretna, Nevada were the richest towns in their respective states - but with much lower median household incomes.

THE RICHEST TOWNS IN EACH U.S. STATE 

Hidden Hills, California >$250,000
Chevy Chase, Maryland >$250,000
Short Hills, New Jersey $235,799
Piney Point Village, Texas $233,636
Scarsdale, New York $232,422
Cherry Hills Village, Colorado $231,774
Kenilworth, Illinois $229,792
Coldstream, Ohio $220,263
Mission Hills, Kansas $219,107
Great Falls, Virginia $217,552
Belle Meade, Tennessee $213,375
Clyde Hill, Washington $210,500
Darien, Connecticut $200,724 
River Hills, Wisconsin $193,438
Clarkson Valley, Missouri $188,000
Dover, Massachusetts $185,515
Fox Chapel, Pennsylvania $183,750
Anchorage, Kentucky $160,956
Marvin, North Carolina $160,093
Greenville, Delaware $156,635
Orchard Lake Village, Michigan $153,289
Kiawah Island, South Carolina $150,833
North Oaks, Minnesota $144,112
Paradise Valley, Arizona $139,524
Maunawili, Hawaii $137,143
Mountain Brook, Alabama $135,833
Emigration Canyon, Utah $135,469
Berkeley Lake, Georgia $131,944
Indian River Shores, Florida $129,885
Nichols Hills, Oklahoma $124,934
Shorewood Forest, Indiana $118,984
Bayou Country Club, Louisiana $118,571
Rafter J Ranch, Wyoming $117,526
White Rock, New Mexico $112,356
Robins, Iowa $111,652
Hidden Spring, Idaho $108,750
Bethany, Oregon $107,372
East Valley, Nevada $105,536
Dakota Dunes, South Dakota $104,327
Cumberland Center, Maine $101,375
Montana City, Montana $98,362
Gateway, Arkansas $97,269
Madison, Mississippi $96,780
South Hooksett, New Hampshire $93,371
Horace, North Dakota $88,750
Ashaway, Rhode Island $84,500
Maumelle, Arizona $82,122
Shepherdstown, West Virginia $81,029
Jericho, Vermont $78,618
Gretna, Nevada $77,818

Read more: http://www.dailymail.co.uk/news/article-2959361/The-United-States-Affluence-Map-shows-richest-towns-state-Hidden-Hills-California-Chevy-Chase-Maryland-ranking-10.html#ixzz3SBy7bg2P
Follow us: @MailOnline on Twitter | DailyMail on Facebook

18 Feb 2015

ONTARIO MEDICAL ASSOCIATION LOOKING FOR NEW CEO STARTING AUGUST 2015

250 staff 
Two floors in elegant building with indoor parking: 150 BLOOR WEST.(at Avenue Road)  In most fashionable area of Toronto.Louis Vuitton & Tiffany next door. Park Hyatt hotel opposite. Royal Ontario Museum and Gardiner ceramics museum across the street.

Would suit applicant with MBA, MHSc & LLB/JD.

Contact ODGERS BERNDTSON AGENCY

RESUME advice from RANDSTAD Exec.Recruiter Danielle KRAUSE

S.A.M.
  • What you Saved (as in time or money) - "reduced the month-end close process by four days," or, "saved $100,000 annually by renegotiating vendor contracts"
  • What you Achieved (as in awards or goals met) - "chosen for the annual Company Spirit award for contributions to department," or, "completed systems implementation project"
  • What you Made (as in something you actually created) - "redesigned aging report in Excel to track all past due accounts," or "implemented internal control procedures to reduce data entry error"

16 Feb 2015

MEASLES IN TORONTO Parents refusing to immunise (Stats Can: 46% Canucks "FUNCTIONALLY ILLITERATE").

MDs in Toronto now have chance to see Clinical effects of Measles including KOPLIK SPOTS.Henry KOPLIK MD(Columbia ,NY) 1858-1927 ."whonamedit"

H. Koplik:
The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membrane.
Archives of Pediatrics, New York, 1896; 13: 918-922.

Koplik spots not mentioned in OSLER "Principle & Practice of Medicine"  1892  D.Appleton,NY
Measles: pp 77-81.

"AMONG THE ERUPTIVE FEVERS IT RANKS THIRD IN THE DEATH-RATE",  Osler.

Late (1916-2010) U.Tor Prof.(Epid & Biometrics) W.HARDING le RICHE: MD(Wit.,SA) MPH(Harvard) FRCPC
World incidence and prevalence of the major communicable diseases In: Health and Mankind.(1967) Churchill.
"Cause of deaths
No.7 MEASLES  2.95%"